Bayforest Capital’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$127K Buy
+1,628
New +$111K 0.12% 343
2025
Q3
– Sell
-62
Closed -$3.23K – 815
2025
Q2
$3.23K Buy
62
+16
+35% +$910 ﹤0.01% 683
2025
Q1
$2.94K Buy
+46
New +$2.67K ﹤0.01% 699

Other funds holding HALO

Bayforest Capital's HALO Position: Q2 2026 in Review

Bayforest Capital opened a new position in Halozyme (HALO) in Q2 2026: 1,628 shares worth $127K. The stake represents 0.12% of the portfolio and ranks #343 among its holdings. This is a return to the name: Bayforest Capital previously reported a position in HALO as recently as Q2 2025.

Bayforest Capital first reported a position in HALO in Q1 2025 and has held it in 3 quarters since. 674 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Bayforest Capital held 1,628 shares of Halozyme worth $127K as of Q2 2026.
  • Halozyme was a new Bayforest Capital position in Q2 2026.
  • Halozyme made up 0.12% of Bayforest Capital's portfolio in Q2 2026, its #343 holding.
  • Bayforest Capital first reported a position in Halozyme in Q1 2025 and has held it in 3 quarters since.
  • 674 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Bayforest Capital's 13F filing for Q2 2026, filed 5 Aug 2026.